Je-Tae Woo

The Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway Regulates Osteoclastogenesis in RAW264.7 Cells

Hiroaki Hirotani, Nathaniel A. Tuohy, Je-Tae Woo et al. · Journal of Biological Chemistry · 2004 · 249 citations · Full text

Sclerostin, Raw264.7 Cells, Immunology +16

Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts

Je-Tae Woo, Makoto Kawatani, Masanori Kato et al. · Proceedings of the National Academy of Sciences · 2006 · 82 citations · Full text

Bone Disease, Reveromycin A, Excessive Bone Loss +15

Effects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in vitro

Kaoru Igarashi, Je-Tae Woo, Paula H. Stern · Biochemical Pharmacology · 2002 · 44 citations

Bone Disease, Bone Resorption, Medicine +9

Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NFκB ligand (RANKL) or tumor necrosis factor-α (TNF-α)

Je-Tae Woo, Hiroshi Nakagawa, Annette M. Krecic et al. · Biochemical Pharmacology · 2004 · 39 citations

Inflammation, Molecular Pharmacology, Medicine +11

Development of high-throughput screening system for osteogenic drugs using a cell-based sensor

Hironori Hojo, Kazuyo Igawa, Shinsuke Ohba et al. · Biochemical and Biophysical Research Communications · 2008 · 23 citations

Tissue Engineering, Osteogenic Drugs, Cell-based Sensor +12